Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Kitano (2007)
A robustness-based approach to systems-oriented drug designNature Reviews Drug Discovery, 6
Jasmin Saric, H. Engelken, Uwe Reyle (2008)
Discovering biomedical knowledge from the literature.Methods in molecular biology, 484
C. Tamerler, M. Sarikaya (2007)
Molecular biomimetics: utilizing nature's molecular ways in practical engineering.Acta biomaterialia, 3 3
R. Altman, C. Bergman, J. Blake, C. Blaschke, A. Cohen, F. Gannon, L. Grivell, U. Hahn, W. Hersh, L. Hirschman, L. Jensen, Martin Krallinger, B. Mons, S. O’Donoghue, M. Peitsch, D. Rebholz-Schuhmann, H. Shatkay, A. Valencia (2008)
Text mining for biology - the way forward: opinions from leading scientistsGenome Biology, 9
T. Kenakin (2007)
Allosteric Agonist ModulatorsJournal of Receptors and Signal Transduction, 27
J.Stoffers Huub, Lindgren Erik, J. Gérard, J.H.Raat Nicolaas, V.Westerhoff Hans (1992)
METASIM: object-oriented modelling of cell regulation.Bioinformatics, 8
R. Mancera (2007)
Molecular modeling of hydration in drug design.Current opinion in drug discovery & development, 10 3
X. Zheng, T. Chan (2002)
Chemical genomics: a systematic approach in biological research and drug discovery.Current issues in molecular biology, 4 2
John Robinson, S. DeMarco, F. Gombert, K. Moehle, D. Obrecht (2008)
The design, structures and therapeutic potential of protein epitope mimetics.Drug discovery today, 13 21-22
J. Vagner, Hongchang Qu, V. Hruby (2008)
Peptidomimetics, a synthetic tool of drug discovery.Current opinion in chemical biology, 12 3
Markus Seifert, M. Lang (2008)
Essential factors for successful virtual screening.Mini reviews in medicinal chemistry, 8 1
Esther Marco, F. Gago (2007)
Overcoming the Inadequacies or Limitations of Experimental Structures as Drug Targets by Using Computational Modeling Tools and Molecular Dynamics SimulationsChemMedChem, 2
R. Morphy, C. Kay, Z. Rankovic (2004)
From magic bullets to designed multiple ligands.Drug discovery today, 9 15
B. Kholodenko (2006)
Cell-signalling dynamics in time and spaceNature Reviews Molecular Cell Biology, 7
H. Bonarius, G. Schmid, J. Tramper (1997)
Flux analysis of underdetermined metabolic networks: the quest for the missing constraints.Trends in Biotechnology, 15
C. Langmead (2007)
Screening for Positive Allosteric Modulators: Assessment of Modulator Concentration-Response Curves as a Screening ParadigmJournal of Biomolecular Screening, 12
J. Ricard (2004)
Reduction, integration and emergence in biochemical networksBiology of the Cell, 96
J. Leith, L. Faulkner, S. Bliven, S. Michelson (1988)
Compositional stability of artificial heterogeneous tumors in vivo: use of mitomycin C as a cytotoxic probe.Cancer research, 48 10
W. Bosl (2007)
Systems biology by the rules: hybrid intelligent systems for pathway modeling and discoveryBMC Systems Biology, 1
L. Matthews, Gopal Gopinath, M. Gillespie, M. Caudy, David Croft, B. Bono, P. Garapati, J. Hemish, H. Hermjakob, B. Jassal, Alexander Kanapin, S. Lewis, S. Mahajan, Bruce May, E. Schmidt, Imre Vastrik, Guanming Wu, E. Birney, L. Stein, P. D’Eustachio (2008)
Reactome knowledgebase of human biological pathways and processesNucleic Acids Research, 37
M. Suderman, M. Hallett (2007)
Tools for visually exploring biological networksBioinformatics, 23 20
J. Dancey, Helen Chen (2006)
Strategies for optimizing combinations of molecularly targeted anticancer agentsNature Reviews Drug Discovery, 5
Niu Huang, C. Kalyanaraman, K. Bernacki, M. Jacobson (2006)
Molecular mechanics methods for predicting protein-ligand binding.Physical chemistry chemical physics : PCCP, 8 44
C. Gend, J. Snoep (2008)
Systems biology model databases and resources.Essays in biochemistry, 45
T. Fox, Jan Kriegl (2006)
Machine learning techniques for in silico modeling of drug metabolism.Current topics in medicinal chemistry, 6 15
J. Snoep (2005)
The Silicon Cell initiative: working towards a detailed kinetic description at the cellular level.Current opinion in biotechnology, 16 3
J. Fitzgerald, B. Schoeberl, U. Nielsen, P. Sorger (2006)
Systems biology and combination therapy in the quest for clinical efficacyNature Chemical Biology, 2
Kanae Oda, Yukiko Matsuoka, Akira Funahashi, H. Kitano (2005)
A comprehensive pathway map of epidermal growth factor receptor signalingMolecular Systems Biology, 1
B. Villoutreix, N. Renault, D. Lagorce, O. Sperandio, M. Montès, M. Miteva (2007)
Free resources to assist structure-based virtual ligand screening experiments.Current protein & peptide science, 8 4
H. Kacser, Burns Ja (1995)
The control of flux.Biochemical Society transactions, 23 2
M. Totrov, R. Abagyan (2008)
Flexible ligand docking to multiple receptor conformations: a practical alternative.Current opinion in structural biology, 18 2
E. Trucco (1965)
Mathematical models for cellular systems. The von foerster equation. Part IIBulletin of Mathematical Biology, 27
P. Bradley, K. Misura, D. Baker (2005)
Toward High-Resolution de Novo Structure Prediction for Small ProteinsScience, 309
G. Lushington, Jian-xin Guo, Jenna Wang (2007)
Whither combine? New opportunities for receptor-based QSAR.Current medicinal chemistry, 14 17
T. Zal (2008)
Visualization of protein interactions in living cells.Advances in experimental medicine and biology, 640
E. Crampin, S. Schnell, P. McSharry (2004)
Mathematical and computational techniques to deduce complex biochemical reaction mechanisms.Progress in biophysics and molecular biology, 86 1
S. Rubinow (1968)
A maturity-time representation for cell populations.Biophysical journal, 8 10
M. Stoermer (2006)
Current status of virtual screening as analysed by target class.Medicinal chemistry (Shariqah (United Arab Emirates)), 2 1
A. Kümmel, S. Panke, Matthias Heinemann (2006)
Systematic assignment of thermodynamic constraints in metabolic network modelsBMC Bioinformatics, 7
K. Phillips, S. Bebber, A. Issa (2006)
Diagnostics and biomarker development: priming the pipelineNature Reviews Drug Discovery, 5
J. Hornberg, F. Bruggeman, B. Binder, C. Geest, A. Vaate, J. Lankelma, R. Heinrich, H. Westerhoff (2004)
Principles behind the multifarious control of signal transductionThe FEBS Journal, 272
Ségolène Galandrin, Geneviève Oligny-Longpré, M. Bouvier (2007)
The evasive nature of drug efficacy: implications for drug discovery.Trends in pharmacological sciences, 28 8
J. Collado-Vides (1991)
A syntactic representation of units of genetic information--a syntax of units of genetic information.Journal of theoretical biology, 148 3
[This chapter represents a mix of reductionist and holistic tools. Molecular screens and Biomimetics represent advanced reductionist approaches—the former are well established in the industry, although still developing. Similarly, the collateral efficacy/permissive antagonism concept may add to this effort, possibly generating new targets. Solving different co-drugging modalities represents a typical SB approach. Likewise, text mining does add to the holistic (global) effort. Tools to analyze biochemical networks and the phenomenon of emergence may lead to the establishment of ‘new biology’ or computational systems biology (CSB). Reactome analysis and bioinformatics tools only reinforce this effort. The level of development of the above quantitative tools is not uniform: some are advanced and mature (e.g., molecular screens), some require more inputs and are undergoing rapid evolution.]
Published: Jan 4, 2012
Keywords: Biochemical Network; Computational System Biology; Detailed Kinetic Model; Multistage Target; Unstructured Textual Data
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.